Pakistan's pharma industry has recorded a milestone accomplishment, detailing its most noteworthy ever quarterly sales of Rs237 billion in the final quarter of FY24. This denotes a 25% year-on-year (YoY) increment, as indicated by information delivered by IQVIA, a leading healthcare data organization.
On April 2, 2024, the Lahore court abandoned the stay order, permitting the liberation of MRPs - Maximum Retail Prices of medications to continue.
This great administrative decision has prompted an entire year FY24 pharma sales figure of Rs916 billion, mirroring a 22% YoY growth.
#PharmaIndustry #Growth #Increase #FY2024 #Pakistan
